Cardiac magnetic resonance postcontrast T1 time is associated with outcome in patients with heart failure and preserved ejection fraction

Circulation: Cardiovascular Imaging

Volumn 6, Issue 6, 2013, Pages 1056-1065

  Mascherbauer, Julia ^a   Marzluf, Beatrice A ^c   Tufaro, Caroline ^a   Pfaffenberger, Stefan ^a   Graf, Alexandra ^a   Wexberg, Paul ^d   Panzenböck, Adelheid ^a   Jakowitsch, Johannes ^a   Bangert, Christine ^b   Laimer, Daniela ^b   Schreiber, Catharina ^a   Karakus, Gültekin ^e   Hülsmann, Martin ^a   Pacher, Richard ^a   Lang, Irene M ^a   Maurer, Gerald ^a   Bonderman, Diana ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Universitatsklinik fur Dermatologie   (Austria)

^c OTTO WAGNER HOSPITAL   (Austria)

^d KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

^e Acibadem Maslak Hospital Eye Clinic   (Turkey)

Author keywords

Hypertension; Magnetic resonance imaging; Prognosis; Pulmonary

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; COLLAGEN; GADOBUTROL; GADOLINIUM PENTETATE;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CANCER MORTALITY; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; HEART AMYLOIDOSIS; HEART ARREST; HEART CATHETERIZATION; HEART DISEASE; HEART EJECTION FRACTION; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART MUSCLE BIOPSY; HEMODYNAMIC PARAMETERS; HISTOCHEMISTRY; HOSPITAL PATIENT; HUMAN; HUMAN TISSUE; LIMIT OF QUANTITATION; LONGITUDINAL STUDY; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MYOCARDIAL EXTRACELLULAR MATRIX; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PANCREAS CANCER; POSTCONTRAST T1 TIME; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY HYPERTENSION; RADIOLOGICAL PARAMETERS; TISSUE DOPPLER IMAGING; TRANSTHORACIC ECHOCARDIOGRAPHY;

HYPERTENSION, PULMONARY; MAGNETIC RESONANCE IMAGING; PROGNOSIS;

AGED; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; PROGNOSIS; PROSPECTIVE STUDIES; ROC CURVE; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 84892143321     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.113.000633     Document Type: Article

References (34)

1. Hogg K, Swedberg K, McMurray J. Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol. 2004; 43:317-327.
2. McMurray JJ, Adamopoulos S, Anker S.D., Auricchio A., Böhm M, Dickstein K., Falk V, Filippatos G, Fonseca C., Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A; ESC Committee for Practice Guidelines. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012; 33:1787-1847.
3. Bhatia RS, Tu JV, Lee D.S., Austin PC, Fang J, Haouzi A, Gong Y., Liu PP Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med. 2006; 355:260-269.
4. Lee DS, Gona P, Vasan R.S., Larson MG, Benjamin EJ, Wang TJ, Tu J.V., Levy D. Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute. Circulation. 2009; 119:3070-3077.
5. Martos R, Baugh J, Ledwidge M., O'Loughlin C, Conlon C, Patle A., Donnelly SC, McDonald K. Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation. 2007; 115:888-895.
6. Borbély A., van der Velden J, Papp Z, Bronzwaer JG, Edes I, Stienen GJ, Paulus WJ. Cardiomyocyte stiffness in diastolic heart failure. Circulation. 2005; 111:774-781.
7. Jellis C, Martin J, Narula J., Marwick TH Assessment of nonischemic myocardial fibrosis. J Am Coll Cardiol. 2010; 56:89-97.
8. Iles L, Pfluger H, Phrommintikul A., Cherayath J, Aksit P, Gupta S.N., Kaye DM, Taylor AJ Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol. 2008; 52:1574-1580.
9. Flett AS, Sado DM, Quarta G, Mirabel M., Pellerin D, Herrey AS, Hausenloy D.J., Ariti C., Yap J, Kolvekar S, Taylor A.M., Moon JC Diffuse myocardial fibrosis in severe aortic stenosis: an equilibrium contrast cardiovascular magnetic resonance study. Eur Heart J Cardiovasc Imaging. 2012; 13:819-826.
10. Paulus WJ, Tschöpe C, Sanderson J.E., Rusconi C., Flachskampf FA, Rademakers FE, Marino P, Smiseth O.A., De Keulenaer G, Leite-Moreira AF, Borbély A, Edes I., Handoko ML, Heymans S, Pezzali N, Pieske B., Dickstein K, Fraser AG, Brutsaert DL How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J. 2007; 28:2539-2550.
11. Lang RM, Bierig M, Devereux R.B., Flachskampf FA, Foster E, Pellikka PA, Picard M.H., Roman MJ, Seward J, Shanewise JS, Solomon S.D., Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005; 18:1440-1463.
12. Lang RM, Bierig M, Devereux R.B., Flachskampf FA, Foster E, Pellikka PA, Picard M.H., Roman MJ, Seward J, Shanewise J, Solomon S., Spencer KT, St John Sutton M, Stewart W; American Society of Echocardiography's Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr. 2006; 7:79-108.
13. Feigenbaum H, Mastouri R, Sawada S. A practical approach to using strain echocardiography to evaluate the left ventricle. Circ J. 2012; 76:1550-1555.
14. Baim DS. Grossmańs Cardiac Catheterization, Angiography, and Intervention. Philadelphia, PA: Lippincott Williams & Wilkins; 2006.
15. Garvey W, Fathi A, Bigelow F., Carpenter B, Jimenez C. A combined elastic, fibrin and collagen stain. Stain Technol. 1987; 62:365-368.
16. Barka T, Anderson PJ In: Sheehan DC, Hrapchak BB, eds. Theory and Practice of Histotechnology. Columbus, OH: Battelle Press; 1962.
17. Lopez-De Leon A, Rojkind M. A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections. J Histochem Cytochem. 1985; 33:737-743.
18. Kramer CM, Barkhausen J, Flamm S.D., Kim RJ, Nagel E; Society for Cardiovascular Magnetic Resonance Board of Trustees Task Force on Standardized Protocols. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. J Cardiovasc Magn Reson. 2008; 10:35.
19. Ling LH, Kistler PM, Ellims A.H., Iles LM, Lee G, Hughes GL, Kalman J.M., Kaye DM, Taylor AJ Diffuse ventricular fibrosis in atrial fibrillation: noninvasive evaluation and relationships with aging and systolic dysfunction. J Am Coll Cardiol. 2012; 60:2402-2408.
20. Shah AM, Solomon SD Phenotypic and pathophysiological heterogeneity in heart failure with preserved ejection fraction. Eur Heart J. 2012; 33:1716-1717.
21. Persson H, Lonn E, Edner M., Baruch L, Lang CC, Morton J.J., Ostergren J., McKelvie RS; Investigators of the CHARM Echocardiographic Substudy-CHARMES. Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence: results from the CHARM Echocardiographic Substudy-CHARMES. J Am Coll Cardiol. 2007; 49:687-694.
22. Zile MR, Gottdiener JS, Hetzel S.J., McMurray JJ, Komajda M, McKelvie R, Baicu C.F., Massie BM, Carson PE; I-PRESERVE Investigators. Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction. Circulation. 2011; 124:2491-2501.
23. Lam CS, Donal E, Kraigher-Krainer E, Vasan RS Epidemiology and clinical course of heart failure with preserved ejection fraction. Eur J Heart Fail. 2011; 13:18-28.
24. Lam CS, Roger VL, Rodeheffer R.J., Borlaug BA, Enders FT, Redfield MM Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J Am Coll Cardiol. 2009; 53:1119-1126.
25. Jellis C, Wright J, Kennedy D., Sacre J, Jenkins C, Haluska B., Martin J, Fenwick J, Marwick TH Association of imaging markers of myocardial fibrosis with metabolic and functional disturbances in early diabetic car-diomyopathy. Circ Cardiovasc Imaging. 2011; 4:693-702.
26. Sueyoshi E, Sakamoto I, Uetani M. Contrast-enhanced myocardial inversion time at the null point for detection of left ventricular myocardial fi-brosis in patients with dilated and hypertrophic cardiomyopathy: a pilot study. AJR Am J Roentgenol. 2010; 194:W293-W298.
27. Messroghli DR, Niendorf T, Schulz-Menger J, Dietz R., Friedrich MG T1 mapping in patients with acute myocardial infarction. J Cardiovasc Magn Reson. 2003; 5:353-359.
28. Kellman P, Wilson JR, Xue H, Ugander M., Arai AE Extracellular Volume fraction mapping in the myocardium, part 1: evaluation of an automated method. J Cardiovasc Magn Reson. 2012; 14:63.
29. Ugander M, Oki AJ, Hsu L.Y., Kellman P., Greiser A, Aletras AH, Sibley C.T., Chen MY, Bandettini WP, Arai AE Extracellular Volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. Eur Heart J. 2012; 33:1268-1278.
30. Flett AS, Hayward MP, Ashworth M.T., Hansen MS, Taylor AM, Elliott PM, McGregor C, Moon JC Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation. 2010; 122:138-144.
31. Ellims AH, Iles LM, Ling L.H., Hare JL, Kaye DM, Taylor AJ Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction. J Cardiovasc Magn Reson. 2012; 14:76.
32. Paulus WJ, Tschöpe C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol. 2013; 62:263-271.
33. Leung CC, Moondra V, Catherwood E., Andrus BW Prevalence and risk factors of pulmonary hypertension in patients with elevated pulmonary venous pressure and preserved ejection fraction. Am J Cardiol. 2010; 106:284-286.
34. Dini FL, Demmer RT, Simioniuc A, Morrone D., Donati F, Guarini G, Orsini E., Caravelli P, Marzilli M, Colombo PC Right ventricular dysfunction is associated with chronic kidney disease and predicts survival in patients with chronic systolic heart failure. Eur J Heart Fail. 2012; 14:287-294.